Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 82 for:    GRAZOPREVIR ANHYDROUS AND ELBASVIR

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis (STREAGER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02973503
Recruitment Status : Completed
First Posted : November 25, 2016
Last Update Posted : October 28, 2019
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
LC2 PHARMA
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 10, 2018
Actual Study Completion Date : April 2019